Key Developments: I'rom Holdings Co Ltd (2372.T)

2372.T on Tokyo Stock Exchange

737JPY
2:00am EDT
Price Change (% chg)

¥2 (+0.27%)
Prev Close
¥735
Open
¥731
Day's High
¥747
Day's Low
¥731
Volume
17,500
Avg. Vol
58,568
52-wk High
¥1,750
52-wk Low
¥569

Search Stocks

Latest Key Developments (Source: Significant Developments)

I'rom Holdings subsidiary to acquire shares in Japan-based company
Wednesday, 2 Apr 2014 02:30am EDT 

I'rom Holdings Co Ltd:Says subsidiary I'rom Co., Ltd. will acquire shares in a Japan-based company engaged in site management organization (SMO) business, to hold majority stake in the Japan-based company.Other details to be determined.  Full Article

I'rom Holdings Co Ltd's Subsidiary to Form Capital and Business Alliances with Medicross Corp
Thursday, 31 Oct 2013 01:30am EDT 

I'rom Holdings Co Ltd announced that its Tokyo-based subsidiary will form capital and business alliances with Medicross Corp. Through the capital alliance, the subsidiary will issue 200 shares to Medicross and Medicross will hold 20.0% stake in the subsidiary with the Company's stake decreasing from 100% to 80.0%. Through the business alliance, the two companies will cooperate in contract research organization (CRO) business, including source data verification (SDV) specialization clinical test, clinical research using remote system, post-marketing and information security areas.  Full Article

I'rom Holdings Co Ltd's Subsidiary to Acquire Shares of MC Fields Corporation
Tuesday, 29 Oct 2013 06:30am EDT 

I'rom Holdings Co Ltd announced that its wholly owned subsidiary has decided to acquire 1,350 shares (90% stake) of MC Fields Corporation, for JPY 1, from Mayumi Nakano. After the transaction, the Company's subsidiary will hold a 90% stake in MC Fields Corporation.  Full Article

I'rom Holdings Co Ltd to Acquire DNAVEC Corporation through Stock Swap
Friday, 25 Oct 2013 02:00am EDT 

I'rom Holdings Co Ltd announced that it has decided to fully acquire DNAVEC Corporation through stock swap. One share of DNAVEC Corporation's common stock will be exchanged with 0.95 shares of the Company' stock. The Company will use 852,245 shares of its stock in the acquisition. The effective date of the transaction is January 1, 2014. After this, DNAVEC Corporation will become a wholly owned subsidiary of the Company.  Full Article

I'rom Holdings Co Ltd's Subsidiary Wins Lawsuit
Thursday, 29 Aug 2013 02:30am EDT 

I'rom Holdings Co Ltd announced that its subsidiary I'rom Co.,Ltd. has won a lawsuit, which a Japan-based company filed against the subsidiary regarding debt default and illegal action on leasing contract. According to the judgment by Okayama District Court, the claim by plaintiff was dismissed and the plaintiff has to bear the lawsuit cost.  Full Article

I'rom Holdings Co Ltd Announces Stock Split and Partial Change to Article of Incorporation of Authorized Share Number
Tuesday, 28 May 2013 03:45am EDT 

I'rom Holdings Co Ltd announced that it has decided to split one share of its stock into 10 shares, effective October 1, 2013. After the stock split, the total share outstanding will become 9,351,420. The Company has received approval from the shareholders meeting to make partial change to its article of incorporation. Based on change to article five, the Company will increase total number of authorized shares from 3,728,168 shares to 37,281,680 shares.  Full Article

I'rom Holdings Co Ltd to Acquire Shares of IDT Australia Limited
Monday, 6 May 2013 09:00pm EDT 

I'rom Holdings Co Ltd announced that it has decided to acquire 10,000,000 shares of IDT Australia Limited, which is a Australia-based company engaged in the contract manufacturing organization and contract research organization business, for AUD 0.20 per share or AUD 2 million in total, through a private placement, effective May 10, 2013. After this, the Company will hold an 18.8% stake in IDT Australia Limited, up from 0.0%.  Full Article

I'rom Holdings Co Ltd's Subsidiary to Acquire Japan-based Company
Monday, 4 Mar 2013 01:30am EST 

I'rom Holdings Co Ltd announced that its subsidiary has decided to acquire 30 shares (100% stake) of a Japan-based company, which is engaged in SMO business, for JPY 200 million.  Full Article

I'rom Holdings Co Ltd Announces Extraordinary Profit for Q3 of FY 2013; Cancels Expected Extraordinary Profit for Q3 of FY 2013; Raises Consolidated Full-year Outlook for FY 2013
Wednesday, 13 Feb 2013 01:00am EST 

I'rom Holdings Co Ltd announced that it will record a JPY 160 million extraordinary profit on the selling of medical product business, for the third quarter of the fiscal year ending March 2013. In addition, the Company has canceled the expected record of JPY 238 million extraordinary profit on selling of exclusive distribution right, which was announced on November 27, 2012, due to the cancellation of the exclusive distribution right selling agreement, for the third quarter of the fiscal year ending March 2013. The Company has raised its consolidated full-year outlook for revenue from JPY 6,370 million to JPY 6,430 million, operating profit from JPY 210 million to JPY 300 million, ordinary profit from JPY 60 million to JPY 450 million, net profit from JPY 1,100 million to JPY 1,540 million and earning per share from JPY 1,176.29 to JPY 1,646.81, for the fiscal year ending March 2013. This is due to the increased sales, the cost reduction and the record of extraordinary profit.  Full Article

I'rom Holdings Co Ltd to Sell Property and Expects Extraordinary Profit for Q3 of FY 2013; Amends Full-year Consolidated Outlook for FY 2013
Tuesday, 27 Nov 2012 02:00am EST 

I'rom Holdings Co Ltd announced that it has decided to sell exclusive distribution right at the price of JPY 238 million, on December 26, 2012. As a result, the Company expects the extraordinary profit of JPY 238 million caused by sale of exclusive distribution right, for the third quarter of the fiscal year ending March 31, 2013. The Company also has reaffirmed its full-year consolidated outlook for revenue of JPY 6,370 million, operating profit of JPY 210 million, ordinary profit of JPY 60 million, and raised its full-year consolidated outlook for net profit from JPY 900 million to JPY 1,100 million, and earnings per share from JPY 962.42 to JPY 1,176.29, for the fiscal year ending March 31, 2013. This is due to the extraordinary profit for sale of exclusive distribution right.  Full Article

Search Stocks